Spirocyclopropyl amides and acids and their therapeutic applications
申请人:——
公开号:US20040204396A1
公开(公告)日:2004-10-14
The present invention relates to the use of compounds of formula (I)
1
for the treatment of epilepsy, bipolar disorder, psychiatric disorders, migraine, pain, or movement disorders, and to provide neuroprotection.
SPIROCYCLOPROPYL AMIDES AND ACIDS AND THEIR THERAPEUTIC APPLICATIONS
申请人:Abbott Laboratories
公开号:EP1558230A1
公开(公告)日:2005-08-03
US7932245B2
申请人:——
公开号:US7932245B2
公开(公告)日:2011-04-26
[EN] SPIROCYCLOPROPYL AMIDES AND ACIDS AND THEIR THERAPEUTIC APPLICATIONS<br/>[FR] AMIDES ET ACIDES DE SPIROCYCLOPROPYLE ET LEURS APPLICATIONS THERAPEUTIQUES
申请人:ABBOTT LAB
公开号:WO2004037240A1
公开(公告)日:2004-05-06
The present invention relates to the use of compounds of Formula (I) for the treatment of epilepsy, bipolar disorder, psychiatric disorders, migraine, pain, or movement disorders, and to provide neuroprotection.
Free radical annulation of dichlorocyclobutanones with sequential ring expansion
作者:Paul Dowd、Wei Zhang、Steven J. Geib
DOI:10.1016/0040-4020(95)00093-n
日期:1995.3
reaction of dichloroketene with 1,5-dienes undergo intramolecular freeradical annulation. Lewis acid-promoted ring-opening of the cyclized cyclobutanones then yields novel ringexpansion products. Reaction of (R)-carvone provides an unusual example leading to the formation of a tricyclic dione. The carbonyl group of carvone enhances the radical cyclization and influences the ring-opening pathway.